FindTrial
Sign In

Early Detection of Colorectal Cancer Using Liquid Biopsy

Early Detection of Colorectal Cancer Using Liquid Biopsy Based on Whole Genome Sequencing and Machine Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006319
Enrollment
500
Registered
2021-07-05
Start date
2021-08-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among subjects aged 40 to 85 who visited Asan Medical Center in Seoul for colonoscopy, those who agreed to participate in the study

Exclusion criteria

Exclusion criteria: A history of colorectal cancer, A history of other cancers in the present or within 2 years, A history of colon-related surgery, Patients with inflammatory bowel diseases, such as ulcerative colitis/Crohn's disease, Pregnant and breastfeeding women, An individual who is inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of colorectal cancer by liquid biopsy—

Secondary

MeasureTime frame
Diagnostic accuracy of colorectal advanced adenoma by liquid biopsy—

Countries

Korea, Republic of

Contacts

Public ContactSeung Wook Hong

Asan Medical Center

hswooki@gmail.com+82-2-3010-0160

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026